APA

Wu H., Kong L., Tan Y., Epstein P. N., Zeng J., Gu J., Liang G., Kong M., Chen X., Miao L. & Cai L. (20170828). C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. : Diabetologia.

Chicago

Wu Hao, Kong Lili, Tan Yi, Epstein Paul N, Zeng Jun, Gu Junlian, Liang Guang, Kong Maiying, Chen Xiangmei, Miao Lining and Cai Lu. 20170828. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. : Diabetologia.

Harvard

Wu H., Kong L., Tan Y., Epstein P. N., Zeng J., Gu J., Liang G., Kong M., Chen X., Miao L. and Cai L. (20170828). C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. : Diabetologia.

MLA

Wu Hao, Kong Lili, Tan Yi, Epstein Paul N, Zeng Jun, Gu Junlian, Liang Guang, Kong Maiying, Chen Xiangmei, Miao Lining and Cai Lu. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. : Diabetologia. 20170828.